Chronic obstructive pulmonary disease (COPD) is a leading cause of
mortality and morbidity in older adults worldwide. It can be exacerbated
by other chronic and acute health problems (myocardial infarction,
angina, osteoporosis, respiratory infection, depression, diabetes, and
lung cancer). Although the prevalence of COPD in the elderly is high, it is
often undiagnosed and thus undertreated. Diagnosis is primarily based
on physiological airflow limitation using spirometry. Controversies exist
as to the range of predicted normal values in the elderly, in whom its
clinical presentation may be complicated by other comorbidities. Many
non-pharmacological and pharmacological interventions are available
for managing COPD. However, polypharmacy may pose a challenge
to the management of COPD, as it can interfere with compliance to
optimal therapy. This article highlights the evaluation of COPD in the
elderly and its management.

Mode of access: Internet.